GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75N91022F00007LEIDOS BIOMEDICAL RESEARCH INC

Overview

Award facts

Net obligations
$36.85M
$36,854,529of $36.85M potential value
Outlays (paid to date)
$29.40M
$29.40M paid of $36.85M obligated$29,401,727
Period of performance
Mar 7, 2022 to Dec 31, 2025
Ended
Modifications
5
Latest action Apr 24, 2025
Contract type
Delivery order
PIID 75N91022F00007

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THIS COVID TASK ORDER SUPPORTS NIAIDS NEED TO CONDUCT A TRIAL OF AN ADDITIONAL DOSE VACCINE TO EVALUATE VARIANT VACCINES ALONE OR IN COMBINATION IN AN IMMUNOLOGICALLY DIVERSE POPULATION. THE WORK INCLUDES THE ABILITY TO PROVIDE THE MANAGEMENT, OVERS

Dates and value

Award date
Signed on Mar 7, 2022
Potential end of performance
Dec 30, 2025
Current value
$36,854,529Base and exercised options
Potential value (if all options are exercised)
$36,854,529
Parent contract vehicle
75N91019D00024 (IDC, single award) — 185 orders recorded under it

Obligations by fiscal year of action

  • FY2022: $36,854,529

Total across 1 fiscal year: $36,854,529

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 24, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NameLEIDOS BIOMEDICAL RESEARCH INC
LocationFREDERICK, MD
UEIHV8BH9BPG8Y9
CAGE code3LYK6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLEIDOS HOLDINGS, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
Public health and social services emergency fundProgram activities075-0140, 075-0849, 075-0885, 075-3966Federal accounts (agency financial reports)

Place of performance

Place of performance
Frederick, Maryland 21702-0001
Congressional district (place of performance)
MD-06As reported at the time of the action

Classification and competition

Classification

NAICS
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product or service (PSC)
AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Not reported
Contract pricing
Cost plus fixed feeU

Contract details

Subcontracting plan
Individual subcontract planF
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Mar 7, 2022Base obligation at award: $22,200,553
Latest action
Apr 24, 2025 — Terminated for convenienceModification P00005
Latest substantive action
Apr 24, 2025 — Terminated for convenienceModification P00005
Actions by type
  • Base award1
  • Other administrative action3
  • Terminated for convenience1
  • Letter contract definitized1
6 actions recorded, Mar 7, 2022 to Apr 24, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Environmentally preferableF
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2021/2021-0849-000
  • 075-2021/2023-3966-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0849-000
  • 075-2024/2024-0849-000
Show all 8 accounts
  • 075-2025/2025-0849-000
  • 075-X-0140-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$36,854,529
COVID-19 supplemental outlays
$28,792,069